HHC
Hexahydrocannabinol · HHC · Discovered 1944
Complete guide to HHC (Hexahydrocannabinol), the hydrogenated cannabinoid. Learn about its unique chemistry, effects compared to THC, legal status, safety profile, and how hydrogenation changes cannabinoid properties.
Psychoactive
Yes
Discovered
1944
Effects
7 documented
Benefits
2 studied
Overview
Hexahydrocannabinol (HHC) is a hydrogenated form of THC, first created by American chemist Roger Adams in 1944 by adding hydrogen molecules to Delta-9 THC through a process called hydrogenation — the same chemical process used to convert vegetable oil into margarine. While HHC can be found in trace quantities in cannabis pollen and seeds, it does not occur in meaningful amounts in the plant naturally. Commercial HHC products are produced by hydrogenating hemp-derived CBD or THC.
HHC is notable for its enhanced chemical stability compared to THC. The hydrogenation process saturates the double bond in THC's cyclohexyl ring, making HHC more resistant to oxidation, UV degradation, and heat. This increased stability translates to a longer shelf life and potentially more consistent potency over time. From a consumer effects standpoint, HHC is generally described as producing effects between Delta-8 and Delta-9 THC in intensity — more potent than Delta-8 but slightly less intense than Delta-9.
The HHC molecule exists as two diastereomers: 9R-HHC and 9S-HHC. The 9R form has significantly higher affinity for cannabinoid receptors and is responsible for most of HHC's psychoactive effects, while the 9S form has much weaker activity. Commercial HHC products typically contain a mixture of both forms, and the ratio can vary between manufacturers, leading to inconsistent potency. This diastereomeric variability, combined with limited safety research, has raised concerns among regulators and health professionals.
Mechanism of Action
HHC binds to CB1 receptors with affinity intermediate between Delta-8 and Delta-9 THC. The 9R-HHC diastereomer has significantly higher CB1 binding affinity than the 9S form, which largely determines the psychoactive potency of any given HHC product based on the ratio of these isomers. The hydrogenated ring structure of HHC changes its three-dimensional shape enough to reduce CB1 affinity compared to Delta-9 THC but retain meaningful psychoactive activity. HHC also binds to CB2 receptors, potentially contributing to anti-inflammatory and analgesic effects. Due to its structural similarity to THC, HHC is expected to interact with many of the same secondary targets, including TRP channels, PPARs, and opioid receptors, though these interactions have not been specifically characterized for HHC in published research.
Therapeutic Effects
Potential Benefits
Pain Management
Inferred from structural similarity to THC. No specific clinical studies on HHC for pain. Its CB1 and CB2 receptor activity suggests analgesic potential comparable to other THC variants. Some users report effective pain relief, but this is anecdotal only.
Product Stability
Chemical evidence. HHC's hydrogenated structure makes it significantly more resistant to oxidation and UV degradation than THC. This could be advantageous for pharmaceutical formulations requiring long shelf life and consistent potency, though this advantage has not been explored in clinical drug development.
Side Effects & Risks
- ⚠Psychoactive effects — euphoria, altered perception, impaired coordination
- ⚠Dry mouth and red eyes
- ⚠Inconsistent potency due to variable 9R/9S diastereomer ratios
- ⚠Will likely trigger positive drug tests for THC
- ⚠No published human clinical safety data
- ⚠Quality concerns with manufacturing byproducts
- ⚠Potential for tolerance and dependence similar to THC
Concentration & Sources
Typical Concentration
Trace amounts in cannabis pollen and seeds; 90-99% in commercially produced HHC distillate; 10-50mg per dose in edible products
Found In
Trace amounts in cannabis seeds and pollen. Commercially produced through hydrogenation of hemp-derived CBD or THC. Available in vape cartridges, edibles, tinctures, and dabs.
Legal Status
Legal gray area similar to Delta-8 THC. Not specifically scheduled at the federal level in the US, but the DEA may consider it a THC analog. Banned in several states. Explicitly banned in some European countries. Regulatory status is evolving rapidly.
Research Summary
HHC research is extremely limited despite the compound being first synthesized in 1944. Roger Adams' original work established the basic chemistry but did not explore pharmacology in depth. A small number of studies have examined HHC's receptor binding properties, confirming CB1 activity and establishing the differential potency of the 9R and 9S diastereomers. Beyond basic pharmacology, there are no published clinical trials investigating HHC's therapeutic potential, safety profile, or toxicology in humans. The rapid commercialization of HHC products beginning in 2021 has far outpaced scientific understanding. Research priorities include characterizing the safety of hydrogenated cannabinoid products, establishing the pharmacokinetics and metabolism of HHC, and determining whether its enhanced stability offers meaningful pharmaceutical advantages over existing cannabinoid formulations.
Related Cannabinoids
HHC FAQ
What does HHC feel like compared to THC?
HHC is generally described as producing effects similar to Delta-9 THC but slightly milder — roughly 70-80% of Delta-9's potency. Users report euphoria, relaxation, altered perception, and increased appetite. The experience is often described as smoother and less anxiety-inducing than Delta-9 THC. HHC effects typically last 2-4 hours when inhaled. The subjective experience can vary between products due to differing ratios of 9R-HHC (more active) and 9S-HHC (less active) diastereomers.
Is HHC legal?
HHC's legal status is uncertain and varies by jurisdiction. It is not specifically listed in the US Controlled Substances Act, and some argue it is legal under the 2018 Farm Bill when derived from hemp. However, it could be considered a controlled substance analog under the Federal Analogue Act. Several US states have banned HHC specifically. Some European countries, including Austria and France, have explicitly banned HHC. The regulatory landscape continues to shift rapidly.
Does HHC show up on drug tests?
HHC will very likely cause a positive drug test. While some early marketing claimed HHC was not metabolized into THC-COOH (the standard THC drug test metabolite), this claim has not been substantiated by published research. Given HHC's structural similarity to THC, it is probable that its metabolites cross-react with standard immunoassay drug tests. Until definitive metabolic studies are published, assume HHC will trigger a positive THC drug test.
How is HHC different from THC?
HHC is a hydrogenated form of THC, meaning hydrogen atoms have been added to THC's molecular structure, saturating the double bond in its cyclohexyl ring. This makes HHC more chemically stable (resistant to heat, light, and oxidation) and gives it a longer shelf life than THC. HHC is slightly less potent than Delta-9 THC but more potent than Delta-8. Unlike THC which has one primary active form, HHC exists as two diastereomers (9R and 9S) with different potencies.
Continue Exploring
Disclaimer: Cannabinoid information is provided for educational purposes only. Medical benefits are based on published research and are not intended as medical advice. Individual responses to cannabinoids vary. Always consult a healthcare professional before using cannabis for medical purposes. Legal status information is current as of publication but may change — verify your local laws.